Scientists swap key drug in hopes of boosting survival for tough lung cancer
NCT ID NCT05856695
Summary
This study is testing a new first-line treatment for extensive-stage small cell lung cancer. It combines a different chemotherapy (paclitaxel and carboplatin) with an immunotherapy drug (durvalumab) to see if it works better than the current standard treatment. The main goal is to see if patients live longer with this new combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abbeville - CH
Abbeville, France
-
Amiens - Clinique de l'Europe
Amiens, France
-
Angers - CHU
Angers, France
-
Annemasse - CH
Contamine-sur-Arve, France
-
Besançon - CHU
Besançon, France
-
Bordeaux - CHU
Bordeaux, France
-
Boulogne - Ambroise Paré
Boulogne-Billancourt, France
-
CHU Montpellier
Montpellier, 34295, France
-
CHU Toulouse
Toulouse, 31059, France
-
Caen - CHU Côte de Nacre
Caen, 14000, France
-
Chambéry - CH
Chambéry, France
-
Cholet - CH
Cholet, France
-
Colmar - CH
Colmar, France
-
Créteil - CHI
Créteil, France
-
Dijon - CHU Bocage
Dijon, France
-
Grenoble - CHU
Grenoble, France
-
Le Mans - CHG
Le Mans, France
-
Lyon - URCOT
Lyon, France
-
Marseille - APHM
Marseille, France
-
Marseille - Hôpital Européen
Marseille, France
-
Morlaix - CH
Morlaix, France
-
Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
-
Orléans - CHR
Orléans, France
-
Paris - Bichat
Paris, France
-
Paris - Hôpital Cochin
Paris, France
-
Paris - Tenon
Paris, France
-
Rennes - CHU
Rennes, France
-
Toulon - Sainte Anne HIA
Toulon, France
-
Tours - CHU
Tours, France
-
Vandoeuvre-lès-Nancy - CRLCC
Vandœuvre-lès-Nancy, France
-
Villefranche sur Saône - CH
Villefranche-sur-Saône, France
Conditions
Explore the condition pages connected to this study.